Activation of the retinoid acid receptor β gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells

Anti-Cancer Drugs

Volumn 8, Issue 1, 1997, Pages 56-61

  Côté, Sylvie ^a   Momparler, Richard L ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

5 aza 2' deoxycytidine; colon carcinoma; DNA methylation; retinoic acid; retinoic acid receptor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; AZACITIDINE; DRUG DERIVATIVE; RETINOIC ACID RECEPTOR;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DNA METHYLATION; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE; ADENOCARCINOMA; CELL LINE; COLON TUMOR; DRUG EFFECT; DRUG SCREENING; EXON; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NORTHERN BLOTTING; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; AZACITIDINE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CELL LINE; COLONIC NEOPLASMS; DNA METHYLATION; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; RECEPTORS, RETINOIC ACID; TRETINOIN; TUMOR STEM CELL ASSAY;

EID: 0030614832     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199701000-00007     Document Type: Article

References (34)

1. Piedbois P, Buyse M, Blijham G. et al. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorcctal cancer. J Clin Oncol 1994; 12: 960-9.
2. Fanjul AN, Bouterfa H, Dawson M, Pfahl M. Potential role for retinoic acid receptor-γ in the inhibition of breast cancer cells by selective retinoids and interferons. Cancer Res 1996; 56: 1571-7.
3. Smith MA, Parkinson DR, Cheson BD, Friedman MA. Retinoids in cancer therapy. J Clin Oncol 1992; 10: 839-86.
4. Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444-50.
5. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS, eds, The retinoids, 2nd edn. Orlando, FL: Academic Press 1994: 319-49.
6. de Thé, Del Mar Vivanco-Ruiz M, Tiollais P, Stunnenberg H, Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor-β gene. Nature 1990; 343: 177-80.
7. Benbrook D, Lernhardt E, Pfahl M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 1988; 333:669-72.
8. Brand N, Petkovich M, Krust A, et al. Identification of a second human retinoic acid receptor. Nature 1988; 332: 850-3.
9. Krust A, Kastner P, Petkovich M, Zelent A, Chambon P. A third human retinoic acid receptor, hRARγ. Proc Natl Acad Sci USA 1989; 86: 5310-4.
10. Houle B, Rochette-Egly C, Bradley WEC. Tumor-suppressive effect of retinoic acid receptor β. in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 1993; 90: 985-9.
11. 2. Exp Cell Res 1995; 218: 296-304.
12. Li X-S, Shao ZM, Sheikh MS, et al. Breast carcinoma growth and tumorgenecity is inhibited by retinoic acid nuclear receptor β. Proc Am Ass Cancer Res 1995; 36: 264.
13. Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG. High frequency of retinoic acid receptor-β abnormalities in human lung cancer. Oncogene 1991; 6: 1859-68.
14. Houle B, Leduc F, Bradley WEC. Implications of the RARβ in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer 1991; 3: 358-66.
15. Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell lines. Cancer Res 1991; 51: 3972-81.
16. Caliaro MJ, Marmouget C, Guichard S, et al. Response of four ovarian carcinoma cell lines to all-trans retinoic acid: relationship with induction of differentiation and retinoic acid receptor expression. Int J Cancer 1994; 56: 743-8.
17. Swisshelm K, Ryan K, Lee X, Tsou HC, Peacocke M, Sager R. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Different 1994; 5: 133-41.
18. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. Expression of retinoic acid receptor β mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Different 1995; 6: 1077-88.
19. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1: 686-92.
20. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55: 4525-30.
21. Gonzalez-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995; 55: 4531-5.
22. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994; 91: 9700-4.
23. Greger V, Debus N, Lohmann D, Höpping W, Passarge E, Horsthemke B. Frequency and parental origin of hypermethylated Rb1 alleles in retinoblastoma. Hum Genet 1994; 94: 491-6.
24. INK4BI. Cancer Res 1996; 56: 722-7.
25. Geradts J, Chen JY, Russell EK, Yankaskas JR. Nieves L, Minna JD. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Different 1993; 4: 799-809.
26. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980; 20: 85-93.
27. Momparler RL, Rivard GE, Gyger M. Clinical trial on 5-Aza-2′-deoxycytidine in patients with acute leukemia. Pharmac Ther 1985; 30: 277-86.
28. Richel DJ, Colly LP, Kluin-Nelemans JC, Willemze R. The antileukaemic activity of 5-Aza-2′-deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia. Br J Cancer 1991; 64: 144-8.
29. INK4 protein induction by 5-Aza-2′-deoxycytidine. Oncogene 1995; 11: 1211-6.
30. Côté S, Momparler RL. Antineoplastic action of all-trans retinoic acid and 5-Aza-2′-deoxycytidine on human DLD-1 colon carcinoma cells. Cell Pharmacol 1995; 2: 221-8.
31. Zelent A, Mendelsohn C, Kastner P, et al. Differentially expressed isoforms of the mouse retinoic acid receptor β are generated by usage of two promoters and alternative splicing. EMBO J 1991; 10: 71-81.
32. Lin KT, Momparler RL, Rivard GE. High-performance liquid chromatography of chemical stability of 5-aza-2′-deoxycytidine. J Pharm Sci 1981; 11: 1228-32.
33. Boyes J, Bird A. DNA methylation inhibits transcription indirectly via methyl-CpG binding protein. Cell 1991; 64: 1123-34.
34. Momparler RL. In vitro system for evaluation of combination chemotherapy. Pharmac Tber 1980; 8: 21-35.